New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Eagle Pharmaceuticals, Inc.
EGRX
Shape
US Flag

NASDAQ

11M

Drug Manufacturers - Specialty & Generic

0.85USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-91%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

91%

Quote Panel

Shape
Updated November 13, 2024
1W 5.88 % 1M 50.00 % 3M -76.74 % 1Y -90.08 %

Key Metrics

Shape
  • Market Cap

    11.01M


  • Shares Outstanding

    12.96M


  • Share in Float

    6.28M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.85


  • Average Volume

    191535


  • Beta

    0.62


  • Range

    0.003-9.89


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.eagleus.com


  • Sector

    Healthcare


Fundamentals

Shape

0.19x

P/E Ratio

0.03x

P/S Ratio

0.05x

P/B Ratio

0.3

Debt/Equity

11.3%

Net Margin

$0.8

EPS

How EGRX compares to sector?

P/E Ratio

Relative Strength

Shape

EGRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

N/A

0.24
vs NA

Q2.21

arrow
arrow

+63%

0.93
vs 0.57

Q3.21

arrow
arrow

-52%

0.56
vs 1.17

Q4.21

arrow
arrow

-11%

0.85
vs 0.96

Q1.22

arrow
arrow

+1583%

4.04
vs 0.24

Q2.22

arrow
arrow

+68%

1.56
vs 0.93

Q3.22

arrow
arrow

+100%

1.12
vs 0.56

Q4.22

arrow
arrow

+29%

1.1
vs 0.85

Q1.23

arrow
arrow

-69%

1.26
vs 4.04

Q2.23

arrow
arrow

-24%

1.18
vs 1.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

-10%

41.2M  vs 46M

Q2.21

arrow
arrow

+15%

48.1M  vs 41.9M

Q3.21

arrow
arrow

-20%

39.9M  vs 49.9M

Q4.21

arrow
arrow

-15%

42.3M  vs 49.9M

Q1.22

arrow
arrow

+181%

115.9M  vs 41.2M

Q2.22

arrow
arrow

+54%

74.1M  vs 48.1M

Q3.22

arrow
arrow

+65%

65.9M  vs 39.9M

Q4.22

arrow
arrow

+43%

60.7M  vs 42.3M

Q1.23

arrow
arrow

-43%

66.3M  vs 115.9M

Q2.23

arrow
arrow

-13%

64.6M  vs 74.1M

Return on EquityShape

status-upQoQ

Q3.21

arrow
arrow

-3%

-0.03
vs 0.02

Q4.21

arrow
arrow

-4%

-0.04
vs -0.03

Q1.22

arrow
arrow

+20%

0.2
vs -0.04

Q2.22

arrow
arrow

-4%

-0.04
vs 0.2

Q3.22

arrow
arrow

-1%

-0.01
vs -0.04

Q4.22

arrow
arrow

+3%

0.03
vs -0.01

Q1.23

arrow
arrow

+2%

0.02
vs 0.03

Q2.23

arrow
arrow

+2%

0.02
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

151

151
vs 162

-7%

Q4.22

arrow
arrow

155

155
vs 151

3%

Q1.23

arrow
arrow

155

155
vs 155

NA

Q2.23

arrow
arrow

126

126
vs 155

-19%

Q3.23

arrow
arrow

109

109
vs 126

-13%

Q4.23

arrow
arrow

106

106
vs 109

-3%

Q1.24

arrow
arrow

93

93
vs 106

-12%

Q2.24

arrow
arrow

76

76
vs 93

-18%

Earnings Growth

Latest News